myeloproliferative neoplasms (MPN)

Aplastic Anemia, MDS, and PNH Virtual Support Group - 2022 September

Event Date:

Sat, 09/24/2022 - 10:30am (EDT)

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with

Bone Marrow Disease(s):

Aplastic Anemia, MDS, and PNH Virtual Support Group - 2022 August

Event Date:

Sat, 08/27/2022 - 10:30am (EDT)

AAMDSIF is pleased to announce that we will host a support group for patients diagnosed with

Bone Marrow Disease(s):

Ask the Transplant Expert

Dr. Hemant Murthy provides brief transplant overview and then answers questions from participants. He tackles common and uncommon questions during this presentation, essential for all potential transplant patients and families to learn.

Uma Borate, MBBS

Borate, Uma

Associate Professor, Acute Leukemia Clinical Research Director

The Ohio State University Comprehensive Cancer Center

I am a hematologist specializing in the treatment of

Online Profile:

Associate Professor, Acute Leukemia Clinical Research Director

2022 Seattle, WA, Patient and Family Virtual Conference

Please find the presentation materials below.

Event Date:

Sat, 06/18/2022 - 9:00am (EDT)

Conference Materials:

What is My Diagnosis? - Bart L. Scott, MD

Inherited Disorders - Sioban Keel, MD

Aplastic Anemia - Amy De Zern, MD, MHS

PNH - Bart L. Scott, MD

MDS Non-Transplant Therapies - Rami Komrokji, MD

MPN Non-Transplant Therapies - Ruben Mesa, MD

A Nurse’s Perspective - Costandina Herbert, RN

Leukemic Transformation - Anna Halpern, MD

MDS/MPN Transplant Therapies - H. Joachim Deeg, MD

Living Well with Disease - Krisstina Gowin, DO

Bone Marrow Disease(s):

Conference Event Type:

Patient and Family - Regional One Day

Patients With MPNs Must Be Honest About Their Symptoms, Says Expert

It is incredibly important that patients with MPNs inform their health care team of any symptoms they are experiencing, according to an expert from The Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center.

Because patients with essential thrombocythemia (ET) or polycythemia vera (PV) — rare types of blood cancers known as myeloproliferative neoplasms (MPNs) — experience a range of symptoms that can significantly impact their quality of life, it’s important that patients communicate what they’re experiencing with their health care team.

Suresh Balasubramanian

Balasubramanian, Suresh

Physician, Oncology - Hematology, Oncology - Medical

Karmanos Cancer Institute

Dr. Balasubramanian completed his medical training at Madras Medical College in India. His interest in treating malignant hematology patients started in his advanced training in Singapore in the Department of Hematology and Bone Marrow Transplant.

Online Profile:

Suresh Balasubramanian, M.D.

Catherine J. Lee, MD

Lee, Catherine

Associate Professor of Medicine in the Division of Hematology/BMT

Huntsman Cancer Center, University of Utah

Dr. Catherine Lee's clinical expertise is in Blood and Marrow Transplantation (BMT) & Cellular Therapy. She specializes in autologous and allogeneic hematopoietic cell transplants for the treatment of malignant and benign hematologic diseases in adult patients. She also directs the clinical cellular therapy program and provides both standard-of-care cellular therapy treatments and those being tested in clinical trials.

Online Profile:

Catherine J. Lee, MD